Individual and Community Level Determinants of Vitamin D Deficiency in Pediatric Chronic Kidney Disease
- Institution
- INDIANA UNIVERSITY INDIANAPOLIS, IN
- Principal investigator
- Marciana Lee Laster
- Funding
- $234K
- Duration
- 2025–2027
Moonbase score
Still being scored
Abstract
Children with chronic kidney disease (CKD) are plagued by debilitating cardiovascular and mineral bone disease (CKD-MBD) with cardiovascular mortality rates that are 1000 times greater and fracture rates that are 2 to 3-fold higher than in healthy children. Our previously published work demonstrated population-level differences in CKD-MBD including differences in cardiovascular mortality and differences in the bone biomarkers 25-hydroxyvitamin D and parathyroid hormone (PTH). There is limited understanding of nonclinical correlates like the impact of socioeconomic status on long- and short-term CKD-MBD outcomes. Given the reliance of this life-limiting comorbidity on dietary intake and health behaviors, there is a critical need to define intervenable social-environmental characteristics that impact CKD-MBD outcomes. As such, the objective of this application is to integrate clinical data and the social determinants of health to map the social-environmental exposome and define its relationship to CKD, particularly vitamin D status. The central hypothesis of this research is that adverse social-environmental characteristics increase the risk of CKD comorbidities like vitamin D deficiency. Aim 1 will develop a facile, secure SDOHKIDney dataset that integrates data from electronic health records and geocoded census-level data on the social determinants of health. Aim 2 will use SDOHKIDney to define social-environmental risk factors for vitamin D deficiency. This work will expand upon my current K23 which seeks to understand the genetic contributions to population-level differences in CKD-MBD and set the foundation for investigations of gene by environment interactions and the impact of early CKD interventions on vitamin D on CKD outcomes like progression and hyperparathyroidism.
LOADING MOONBASE SCORE
Questions for INDIANA UNIVERSITY INDIANAPOLIS
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Indiana University Indianapolis69
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension
Ruslan Rafikov · $654K · 2016–2026
- NIH · Indiana University Indianapolis64
IUSM TREAT-AD Center
Bruce T Lamb · $8.3M · 2019–2029
- NIH · Indiana University Indianapolis64
Assay Development and High Throughput Screening (ADHTS) Core
Jeffrey Dage · $3.0M · 2019–2029